StockData
HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Heartflow, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$51.02+2.73 (+5.65%)

Close on Oct 19, 2026

Market cap
$4.41B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 11, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 13, 2026After market close$64.10M$-0.18$-0.07
Q1 FY2026
Ended Mar 31, 2026
May 14, 2026After market close$52.60M$-0.32$-0.16
Q4 FY2025
Ended Dec 31, 2025
Mar 18, 2026After market close$49.10M$-0.29$-0.12
Q3 FY2025
Ended Sep 30, 2025
Nov 12, 2025After market close$46.30M$-1.04$-0.27
Q2 FY2025
Ended Jun 30, 2025
Sep 10, 2025Before market open–––

Company guidance

Outlook given with results on Aug 13, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Non-GAAP gross marginnon-GAAP202682%Raised
Total revenue2026$246.00M to $250.00MRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Heartflow filed with the SEC